Brown S R, Roberts E F, Park J H. "一种的合成方法" [P]. US Patent, US 11223818 B2, 2018-03-14.
发明人郭海燕,张德明,马晓峰. "Method for the Synthesis of (1S,2R,4S,5R)-1-(2-(tert-Butylamino)-2-oxoethyl)-2-((S)-hydroxy(quinolin-4-yl)methyl)-5-vinylquinuclidin-1-ium bromide" [P]. 中国发明专利, 专利号 CN 113447268 B, 授权公告日 2017-07-08.
发明人林芳,冯建国,韩伟. "A Process for Preparing High-Purity (1S,2R,4S,5R)-1-(2-(tert-Butylamino)-2-oxoethyl)-2-((S)-hydroxy(quinolin-4-yl)methyl)-5-vinylquinuclidin-1-ium bromide" [P]. 中国发明专利, 专利号 CN 109479763 B, 授权公告日 2019-06-03.
参考文献 Literature
Zhang Y, Li Q, Chen T. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Nat. Prod., 2015, 982, 418-429.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Rapid Commun. Mass Spectrom., 2023, 1478, 2537-2553.
Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of (1S,2R,4S,5R)-1-(2-(tert-Butylamino)-2-oxoethyl)-2-((S)-hydroxy(quinolin-4-yl)methyl)-5-vinylquinuclidin-1-ium bromide Using HRMS and NMR". Anal. Chem., 2020, 1435, 7919-7938.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Chemosphere, 2014, 1383, 5681-5693.